
FDA says Merck's COVID-19 pill is effective and the agency will seek advice on risks during pregnancy
CBSN
Federal health regulators said an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems during pregnancy. The Food and Drug Administration posted its analysis of the pill ahead of a public meeting next week where academic and other experts will weigh in on its safety and effectiveness. The agency isn't required to follow the group's advice.
The agency's scientists said their review identified several potential risks, including possible toxicity and birth defects. Given those risks the agency will ask its advisers whether the drug should never be given during pregnancy or whether it could be made available in certain cases.
Under that scenario, the agency said the drug would carry warnings about risks during pregnancy, but doctors would still have the option to prescribe it in certain cases where its benefits could outweigh its risks for patients.

Santa Fe, New Mexico — A representative for the estate of actor Gene Hackman is seeking to block the public release of autopsy and investigative reports, especially photographs and police body-camera video related to the recent deaths of Hackman and wife Betsy Arakawa after their partially mummified bodies were discovered at their New Mexico home in February.

In the past year, over 135 million passengers traveled to the U.S. from other countries. To infectious disease experts, that represents 135 million chances for an outbreak to begin. To identify and stop the next potential pandemic, government disease detectives have been discreetly searching for viral pathogens in wastewater from airplanes. Experts are worried that these efforts may not be enough.